NKT Therapeutics Inc. Broadens Scientific Advisory Board with Three New Appointments

WALTHAM, Mass.--(BUSINESS WIRE)--NKT Therapeutics, Inc., a privately held biotechnology company, today announced three new appointments to the company’s scientific advisory board (SAB). The additions include:
MORE ON THIS TOPIC